ACADIA Pharmaceuticals Inc (ACAD)
15.08
+0.08
(+0.53%)
USD |
NASDAQ |
May 31, 16:00
15.08
0.00 (0.00%)
After-Hours: 20:00
ACADIA Pharmaceuticals 1 Year Total Returns (Daily): -35.83% for May 31, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| May 31, 2024 | -35.83% |
| May 30, 2024 | -36.95% |
| May 29, 2024 | -41.00% |
| May 28, 2024 | -39.10% |
| May 24, 2024 | -40.74% |
| May 23, 2024 | -39.15% |
| May 22, 2024 | -36.21% |
| May 21, 2024 | -37.19% |
| May 20, 2024 | -37.89% |
| May 17, 2024 | -34.79% |
| May 16, 2024 | -32.13% |
| May 15, 2024 | -31.65% |
| May 14, 2024 | -30.79% |
| May 13, 2024 | -29.30% |
| May 10, 2024 | -29.56% |
| May 09, 2024 | -29.02% |
| May 08, 2024 | -20.51% |
| May 07, 2024 | -21.34% |
| May 06, 2024 | -22.48% |
| May 03, 2024 | -19.58% |
| May 02, 2024 | -20.11% |
| May 01, 2024 | -21.61% |
| April 30, 2024 | -21.66% |
| April 29, 2024 | -19.83% |
| April 26, 2024 | -17.73% |
| Date | Value |
|---|---|
| April 25, 2024 | -18.90% |
| April 24, 2024 | -17.63% |
| April 23, 2024 | -16.68% |
| April 22, 2024 | -15.43% |
| April 19, 2024 | -15.98% |
| April 18, 2024 | -13.44% |
| April 17, 2024 | -11.25% |
| April 16, 2024 | -5.06% |
| April 15, 2024 | -6.11% |
| April 12, 2024 | -6.54% |
| April 11, 2024 | -3.76% |
| April 10, 2024 | -0.39% |
| April 09, 2024 | -1.09% |
| April 08, 2024 | -3.00% |
| April 05, 2024 | -1.48% |
| April 04, 2024 | -2.33% |
| April 03, 2024 | -2.69% |
| April 02, 2024 | -3.77% |
| April 01, 2024 | -2.98% |
| March 28, 2024 | 0.33% |
| March 27, 2024 | -2.15% |
| March 26, 2024 | -2.47% |
| March 25, 2024 | -2.19% |
| March 22, 2024 | -2.97% |
| March 21, 2024 | -5.35% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-66.72%
Minimum
Dec 01 2021
217.4%
Maximum
Dec 24 2019
18.25%
Average
10.29%
Median
Apr 14 2022
1 Year Total Returns (Daily) Benchmarks
| Regulus Therapeutics Inc | 74.62% |
| Amylyx Pharmaceuticals Inc | -93.03% |
| Alnylam Pharmaceuticals Inc | -19.77% |
| Cassava Sciences Inc | -2.91% |
| Oragenics Inc | -32.21% |